Product Information
CARVEDILOL 12.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0216 per EA under NDC 65862014405. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862014405
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CARVEDILOLApproval Type
Generic (ANDA)
FDA Application
ANDA078332FDA Approved
9/5/2007
TE Code
AB
On Market Since
9/5/2007
Pharmacological Classes
Price Statistics
The NADAC for CARVEDILOL 12.5 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0216 per EA |
|---|---|
| All-time high | $0.0359 (Dec 16, 2015) |
| All-time low | $0.0184 (Nov 20, 2024) |
| 52-week high | $0.0216 |
| 52-week low | $0.0209 |
| Median price | $0.0251 |
| Average price | $0.0260 |
| Largest weekly change | +19.9% (Nov 18, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Carvedilol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CARVEDILOL 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 12.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0216 per EA (NDC 65862014405), effective Sep 30, 2026.
How has the price of CARVEDILOL 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARVEDILOL 12.5 MG TABLET has declined 34.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARVEDILOL 12.5 MG TABLET?
Since Nov 28, 2013, the NADAC for CARVEDILOL 12.5 MG TABLET has ranged from a low of $0.0184 (Nov 20, 2024) to a high of $0.0359 (Dec 16, 2015), with a median of $0.0251 per EA.
Are there cheaper alternatives to CARVEDILOL 12.5 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARVEDILOL 12.5 MG TABLET, is $0.0210 per EA — about 3% below CARVEDILOL 12.5 MG TABLET.
Who manufactures CARVEDILOL 12.5 MG TABLET?
CARVEDILOL 12.5 MG TABLET (NDC 65862014405) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.